Metrics as of 10/16/2026, 04:25 PM (Berlin time), refresh in progress.
Merit Medical Systems, Inc.
Merit Medical Systems, Inc. is a healthcare company headquartered in South Jordan, US, which specializes in the design, development, manufacturing, and worldwide commercialization of disposable medical products. Founded in 1987, the company provides devices crucial for a broad spectrum of diagnostic, therapeutic, and…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
-0.7%
1W
+2.0%
1M
+3.2%
6M
+25.4%
YTD
+0.9%
1Y
+10.0%
2Y
-6.7%
5Y
+27.8%
10Y
+274.9%
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~10% stronger price swings than usual
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 12/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
1 more assignment (Enabler/Second row) Pro-only.
Merit Medical Systems is a provider of single-use medical devices for diagnostic and therapeutic interventions across cardiology, radiology, oncology, critical care, and endoscopy. The portfolio comprises specialized solutions such as vascular access systems, catheters, MEMS sensors, and customized kits for medical procedures. Products are distributed globally through hospitals, medical professionals, and various distribution channels including direct sales, authorized distributors, and OEM partnerships.
PRICE TARGET LOW
US$94.00
CONSENSUS
US$101.88
MEDIAN
US$100.50
PRICE TARGET HIGH
US$114.00
0
STRONG BUY
12
BUY
2
HOLD
1
SELL
0
STRONG SELL
15
TOTAL · Buy
As of: 29/09/2026
P/E
36.37
P/B
3.17
EV/EBITDA
15.72
RETURN ON EQUITY
2.3%
NET MARGIN
9.3%
DEBT/EQUITY
0.49
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
97.6%
FLOAT SHARES
58,301,851
AVG. DAILY VOLUME (30D)
597,272
Lewis Sheri
Peterson Neil W.
Voigt Michel J.
Peterson Neil W.
Voigt Michel J.
Register for free
Register now to see which funds are invested
Merit Medical Systems, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Martha Goldberg Aronson, the company employs around 7,500 people.
The IPO was on 14/05/1990; the stock trades on NASDAQ under the ticker MMSI.
15 analysts rate the stock, the consensus is Buy (as of 29/09/2026).
The average price target is US$101.88, ranging from US$94.00 to US$114.00, with a median of US$100.50.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 10% stronger than usual.
No, Merit Medical Systems currently does not pay a dividend.
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
Clicking "Analyze stock" lets five strategies assess Merit Medical Systems against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.